Fundamental analysis by نرم افزار تحلیل گر بورس - دایموند about Stock دعبید on 8/17/2025

#Daddy Production and sale of new product (Phorize) Dr. Obaidi Pharmaceutical Company has succeeded in producing and supplying a new porreize drug called Vonoprazan General. Iran, after Japan and the United States, is the third country to produce and market this innovative drug. Funding drugs are the result of the research and development of the scientific unit of Dr. Obaidi Pharmaceutical Company and is an effective step in promoting the level of treatment of gastrointestinal diseases in the country. Fundamentalization is the result of the research and development of Dr. Obaidi's pharmaceutical scientific unit and is an effective step in promoting the treatment of gastrointestinal diseases associated with gastric acid disorders (reflux) and H. pilli infection in the country. @dndir